Recently Viewed

News Announcement

Saamya Biotech (India): Statement Of Investor Complaints For The Quarter Ended September 30, 2017

16-Oct-2017 Follow Value Research Online on Google Saamya Biotech (India)

Pursuant to SEBI (LODR) Regulation 13(3), we are herewith furnishing the Statement of Investor Complaints for the quarter ended September 30, 2017.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan